Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 732

1.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
[PubMed - indexed for MEDLINE]
2.

A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.

Reimherr FW, Cunningham LA, Batey SR, Johnston JA, Ascher JA.

Clin Ther. 1998 May-Jun;20(3):505-16.

PMID:
9663366
[PubMed - indexed for MEDLINE]
3.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
4.

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.

Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA.

J Clin Psychiatry. 1997 Dec;58(12):532-7.

PMID:
9448656
[PubMed - indexed for MEDLINE]
5.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
[PubMed - indexed for MEDLINE]
6.

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.

Croft H, Settle E Jr, Houser T, Batey SR, Donahue RM, Ascher JA.

Clin Ther. 1999 Apr;21(4):643-58.

PMID:
10363731
[PubMed - indexed for MEDLINE]
7.

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.

J Clin Psychiatry. 2003 Sep;64(9):1065-74.

PMID:
14628982
[PubMed - indexed for MEDLINE]
8.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
[PubMed - indexed for MEDLINE]
9.

Sexual function during bupropion or paroxetine treatment of major depressive disorder.

Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S.

Can J Psychiatry. 2006 Mar;51(4):234-42.

PMID:
16629348
[PubMed - indexed for MEDLINE]
10.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
11.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
[PubMed - indexed for MEDLINE]
12.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
[PubMed - indexed for MEDLINE]
13.

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.

Kiev A, Feiger A.

J Clin Psychiatry. 1997 Apr;58(4):146-52.

PMID:
9164424
[PubMed - indexed for MEDLINE]
14.

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

Clayton AH, McGarvey EL, Abouesh AI, Pinkerton RC.

J Clin Psychiatry. 2001 Mar;62(3):185-90.

PMID:
11305705
[PubMed - indexed for MEDLINE]
15.

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.

Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.

J Clin Psychiatry. 1996;57 Suppl 2:46-52.

PMID:
8626363
[PubMed - indexed for MEDLINE]
16.

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.

J Clin Psychiatry. 2002 Jul;63(7):577-84.

PMID:
12143913
[PubMed - indexed for MEDLINE]
17.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
[PubMed - indexed for MEDLINE]
18.

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.

JAMA. 1998 Jan 28;279(4):287-91.

PMID:
9450712
[PubMed - indexed for MEDLINE]
19.

Safety profile of sustained-release bupropion in depression: results of three clinical trials.

Settle EC, Stahl SM, Batey SR, Johnston JA, Ascher JA.

Clin Ther. 1999 Mar;21(3):454-63.

PMID:
10321415
[PubMed - indexed for MEDLINE]
20.

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.

J Psychopharmacol. 2010 Aug;24(8):1209-16. doi: 10.1177/0269881109106953. Epub 2009 Nov 25.

PMID:
19939870
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk